<DOC>
	<DOC>NCT02167503</DOC>
	<brief_summary>The study was conducted to evaluate the effect of anti-viral treatment on long-term outcome on patients with chronic hepatitis B.</brief_summary>
	<brief_title>Observational Study on Patients With Chronic Hepatitis B</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B, Chronic</mesh_term>
	<criteria>Male or female, aged over 30 (inclusive) years of old Patients has a history of diagnosis of chronic hepatitis B (ie. HBsAg positive for more than 6 months) For patients with HBsAg positive, patients should be undergoing antiviral treatment For patients with HBsAg negative, a documented evidence of previous antiviral treatment should be provided. Life expectancy is more than 1 year Good treatment compliance. Patients has a history of diagnosis of hepatocellular carcinoma Patients with Child Pugh C Coinfected with HCV, HDV and HIV Suffering from other serious disease Taking part in other clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>